Biotech Blueprint
KalVista’s FDA Win, Merck’s $10B Deal, and CRISPR Momentum — Biotech #60
14 Jul 2025
Description
Subscribe to our free newsletter HERE.Thanks for listening!
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster